These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 6171343

  • 1. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD, Diasio RB.
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA, Briggle TV, Greer S.
    Cancer Res; 1987 May 01; 47(9):2354-62. PubMed ID: 2952263
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
    Takimoto CH, Cadman EC, Armstrong RD.
    Mol Pharmacol; 1986 Jun 01; 29(6):637-42. PubMed ID: 2940459
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM.
    Cancer Res; 1986 Jan 01; 46(1):20-8. PubMed ID: 2415245
    [Abstract] [Full Text] [Related]

  • 7. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H, Furusawa M, Tomoda H, Seo Y, Sugimachi K.
    Anticancer Res; 1993 Jan 01; 13(6A):2201-6. PubMed ID: 8297134
    [Abstract] [Full Text] [Related]

  • 8. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD, Wallace HJ, Diasio RB.
    Cancer Res; 1984 Apr 01; 44(4):1358-63. PubMed ID: 6704957
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC, Stolfi RL, Martin DS.
    Cancer Res; 1988 Dec 01; 48(23):6664-8. PubMed ID: 2460227
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.
    Armstrong RD, Connolly KM, Kaplan AM, Cadman E.
    Cancer Chemother Pharmacol; 1983 Dec 01; 11(2):102-5. PubMed ID: 6226452
    [Abstract] [Full Text] [Related]

  • 11. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S, Cadman E.
    Cancer Res; 1982 Sep 01; 42(9):3550-6. PubMed ID: 6213294
    [Abstract] [Full Text] [Related]

  • 12. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M, Glazer RI.
    Cancer Res; 1985 May 01; 45(5):1953-7. PubMed ID: 2580613
    [Abstract] [Full Text] [Related]

  • 13. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH, Tan YY, Cadman EC, Armstrong RD.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3243-8. PubMed ID: 2444230
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D, Franklin P, Odom G, Peck C, Chwang TL.
    Mol Pharmacol; 1982 Nov 01; 22(3):760-5. PubMed ID: 6218391
    [Abstract] [Full Text] [Related]

  • 15. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
    Diasio RB, Schuetz JD, Wallace HJ, Sommadossi JP.
    Cancer Res; 1985 Oct 01; 45(10):4900-3. PubMed ID: 3928143
    [Abstract] [Full Text] [Related]

  • 16. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.
    Armstrong RD, Cadman E.
    Cancer Res; 1983 Jun 01; 43(6):2525-8. PubMed ID: 6221792
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines.
    Washtien WL.
    Cancer Res; 1984 Mar 01; 44(3):909-14. PubMed ID: 6318987
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M, Yamaizumi Z, Nakajima Y, Nishimura S, Hoshi A.
    Drugs Exp Clin Res; 1988 Mar 01; 14(4):257-63. PubMed ID: 2458897
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.
    Benz C, Santos G, Cadman E.
    Cancer Res; 1983 Nov 01; 43(11):5304-8. PubMed ID: 6616465
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC, Stolfi RL, Martin DS, Spiegelman S.
    Cancer Res; 1984 May 01; 44(5):1847-51. PubMed ID: 6713387
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.